PEI-TZU SU: Open Payments
NPI 1144940586 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 12 payments from 5 companies in 2025. Trend: 2023 $471 · 2024 $965 · 2025 $1,005
Food & beverage: $1,005
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $341 |
| Axsome Therapeutics, Inc. | 5 | $270 |
| Janssen Pharmaceuticals, Inc | 2 | $164 |
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| ABBVIE INC. | 1 | $105 |
Products named: CAPLYTA, Auvelity, SPRAVATO, REXULTI, VRAYLAR.
Industry payments across IN — which companies pay providers there.
